Loading the company…
Loading the company…
In the last ten years FDA made 0 decisions for Genesys Orthopedics Systems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families.
In 2025, Genesys Orthopedics Systems reported engagement with 33 surgeons and other clinicians in the states MedaRep covers, worth $134K in consulting, speaking, meals and travel for its device products, the most in Oklahoma ($64K to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Oklahoma ($64K, 2 engaged), Texas ($20K, 17 engaged), South Dakota ($19K, 2 engaged), Colorado ($13K, 1 engaged), Arizona ($6,364, 1 engaged).